Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001698530-25-000042
Filing Date
2025-05-23
Accepted
2025-05-23 18:19:40
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748038774.html 4  
1 FORM 4 wk-form4_1748038774.xml 4 3318
  Complete submission text file 0001698530-25-000042.txt   4779
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Miller Josh (Reporting) CIK: 0001973899 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 25983740